- Home
- XNCR vs CII Comparison
XNCR vs CII Comparison
Compare XNCR & CII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- CII
- Stock Information
- Founded
- XNCR 1997
- CII 2004
- Country
- XNCR United States
- CII United States
- Employees
- XNCR N/A
- CII N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- CII Investment Bankers/Brokers/Service
- Sector
- XNCR Health Care
- CII Finance
- Exchange
- XNCR Nasdaq
- CII Nasdaq
- Market Cap
- XNCR 1.1B
- CII 939.1M
- IPO Year
- XNCR 2013
- CII N/A
- Fundamental
- Price
- XNCR $13.86
- CII $23.74
- Analyst Decision
- XNCR Buy
- CII
- Analyst Count
- XNCR 11
- CII 0
- Target Price
- XNCR $23.50
- CII N/A
- AVG Volume (30 Days)
- XNCR 1.5M
- CII 78.8K
- Earning Date
- XNCR 11-05-2025
- CII 01-01-0001
- Dividend Yield
- XNCR N/A
- CII 6.17%
- EPS Growth
- XNCR N/A
- CII N/A
- EPS
- XNCR N/A
- CII N/A
- Revenue
- XNCR $150,132,000.00
- CII N/A
- Revenue This Year
- XNCR $22.09
- CII N/A
- Revenue Next Year
- XNCR N/A
- CII N/A
- P/E Ratio
- XNCR N/A
- CII N/A
- Revenue Growth
- XNCR 38.16
- CII N/A
- 52 Week Low
- XNCR $6.92
- CII $16.76
- 52 Week High
- XNCR $27.24
- CII $19.81
- Technical
- Relative Strength Index (RSI)
- XNCR 54.01
- CII 53.17
- Support Level
- XNCR $13.30
- CII $23.92
- Resistance Level
- XNCR $15.16
- CII $24.41
- Average True Range (ATR)
- XNCR 1.14
- CII 0.31
- MACD
- XNCR -0.18
- CII 0.00
- Stochastic Oscillator
- XNCR 50.22
- CII 56.99
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.